Celgene backs four NCI Cancer Centers with $50M to create research consortium
The Tisch Cancer Institute at Mount Sinai and three other National Cancer Institute-designated cancer centers together receive $50 million from pharmaceutical company Celgene to form a research consortium.

The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report®
Jul 29, 2025 View All Press Releases
Mount Sinai Researchers Engineer Rare Immune Cells to Create Powerful New Cancer Vaccine
Jul 21, 2025 View All Press Releases
Mount Sinai’s Cancer Science in the Spotlight at 2025 ASCO
May 29, 2025 View All Press Releases
Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer
May 12, 2025 View All Press Releases
Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases